CN106389962A - Traditional Chinese medicinal composition for preventing and treating lamb colibacillosis, and preparation method and application thereof - Google Patents
Traditional Chinese medicinal composition for preventing and treating lamb colibacillosis, and preparation method and application thereof Download PDFInfo
- Publication number
- CN106389962A CN106389962A CN201610933301.9A CN201610933301A CN106389962A CN 106389962 A CN106389962 A CN 106389962A CN 201610933301 A CN201610933301 A CN 201610933301A CN 106389962 A CN106389962 A CN 106389962A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- lamb
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000019687 Lamb Nutrition 0.000 title claims abstract description 55
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 239000003814 drug Substances 0.000 claims abstract description 103
- 240000001090 Papaver somniferum Species 0.000 claims abstract description 15
- 235000008753 Papaver somniferum Nutrition 0.000 claims abstract description 15
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 15
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 15
- 239000007788 liquid Substances 0.000 claims abstract description 15
- 241001078983 Tetradium ruticarpum Species 0.000 claims abstract description 14
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 6
- 235000008422 Schisandra chinensis Nutrition 0.000 claims abstract description 6
- 244000197580 Poria cocos Species 0.000 claims abstract description 5
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 5
- 241000123887 Pulsatilla chinensis Species 0.000 claims abstract description 5
- 244000234609 Portulaca oleracea Species 0.000 claims abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 44
- 229940079593 drug Drugs 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 11
- 241000206469 Pulsatilla Species 0.000 claims description 8
- 241000245665 Taraxacum Species 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- BCZXFFBUYPCTSJ-UHFFFAOYSA-L Calcium propionate Chemical compound [Ca+2].CCC([O-])=O.CCC([O-])=O BCZXFFBUYPCTSJ-UHFFFAOYSA-L 0.000 claims description 6
- 235000010331 calcium propionate Nutrition 0.000 claims description 6
- 239000004330 calcium propionate Substances 0.000 claims description 6
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 235000010241 potassium sorbate Nutrition 0.000 claims description 5
- 239000004302 potassium sorbate Substances 0.000 claims description 5
- 229940069338 potassium sorbate Drugs 0.000 claims description 5
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 4
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 4
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 4
- 229940010454 licorice Drugs 0.000 claims description 4
- 230000003449 preventive effect Effects 0.000 claims description 4
- 238000011287 therapeutic dose Methods 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 2
- 229940121375 antifungal agent Drugs 0.000 claims description 2
- 239000003429 antifungal agent Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000009806 pulsatillae Substances 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 241000283903 Ovis aries Species 0.000 abstract description 33
- 230000000694 effects Effects 0.000 abstract description 13
- 240000001949 Taraxacum officinale Species 0.000 abstract description 7
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 229940126678 chinese medicines Drugs 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 206010012735 Diarrhoea Diseases 0.000 description 23
- 210000002784 stomach Anatomy 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 210000000952 spleen Anatomy 0.000 description 16
- 201000010099 disease Diseases 0.000 description 15
- 241000219304 Portulacaceae Species 0.000 description 11
- 241000283898 Ovis Species 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 9
- 238000012360 testing method Methods 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 210000003608 fece Anatomy 0.000 description 7
- 230000002265 prevention Effects 0.000 description 7
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 6
- 230000034994 death Effects 0.000 description 6
- 231100000517 death Toxicity 0.000 description 6
- 229920000728 polyester Polymers 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 108010078777 Colistin Proteins 0.000 description 5
- 229960001127 colistin sulfate Drugs 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- ZESIAEVDVPWEKB-ORCFLVBFSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O ZESIAEVDVPWEKB-ORCFLVBFSA-N 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 241000202807 Glycyrrhiza Species 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 210000004915 pus Anatomy 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 206010059866 Drug resistance Diseases 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 208000005156 Dehydration Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000010903 husk Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027783 Moaning Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241000415073 Pulsatilla vulgaris subsp. grandis Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000012936 Sheep disease Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 206010006514 bruxism Diseases 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 229940124579 cold medicine Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000001705 insufficient nutrition Nutrition 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000003771 laboratory diagnosis Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000036457 multidrug resistance Effects 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 235000013613 poultry product Nutrition 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000026841 staggering gait Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/754—Evodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种防治羔羊大肠杆菌病的中药组合物,由以下重量份的组分制备完成:白头翁200±20份;蒲公英100±10份;马齿苋100±10份;吴茱萸180±10份;罂粟壳100±10份;五味子60±5份;焦三仙100±10份;茯苓100±10份;炙甘草60±5份。本发明还提供其制备方法和应用。本发明的优点和有益效果为:1、本发明采用中医兽医疗法,采用纯中药组分,口服下列中药,羔羊食用后治愈快,无副作用,有利于羔羊的生长。2、本发明的中药药液调制简单、使用方便,原料成本低廉,用后无毒性反应、治愈率也高、无残留,是一种理想的防治羔羊大肠杆菌病的药物。The invention provides a traditional Chinese medicine composition for preventing and treating lamb colibacillosis, which is prepared from the following components in parts by weight: 200±20 parts of Pulsatilla chinensis; 100±10 parts of dandelion; 100±10 parts of purslane; 180±10 parts of evodia ; Poppy shell 100 ± 10 parts; Schisandra 60 ± 5 parts; Jiao Sanxian 100 ± 10 parts; Poria cocos 100 ± 10 parts; The invention also provides its preparation method and application. The advantages and beneficial effects of the present invention are as follows: 1. The present invention adopts traditional Chinese medicine veterinary medicine, adopts pure Chinese medicine components, and takes the following Chinese medicines orally. After eating, lambs are cured quickly without side effects, which is beneficial to the growth of lambs. 2. The traditional Chinese medicine liquid of the present invention is simple to prepare, easy to use, low in cost of raw materials, has no toxic reaction after use, has a high cure rate, and has no residue. It is an ideal medicine for preventing and treating lamb colibacillosis.
Description
技术领域technical field
本发明涉及一种中药组合物,具体地涉及一种防治羔羊大肠杆菌病的中药组合物及其制备方法和应用。The invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for preventing and treating lamb colibacillosis, a preparation method and application thereof.
背景技术Background technique
羔羊大肠杆菌病又称羔羊大肠杆菌性腹泻或羔羊白痢病,是由埃希氏大肠杆菌引起的一种急性传染病。该病发生与气候环境差、营养不足、羊舍潮湿、卫生环境差等因素有关,冬春季节舍饲期间最易发生此病。通常该病因羔羊抵抗力下降,舔食了污染的母羊奶头、器具、物品等,病菌通过胃到达肠道,在肠道内大量繁殖而引起肠腔液体大量积聚,使肠腔扩张,刺激肠蠕动,引起腹泻,最终因脱水、酸中毒和电解质平衡紊乱而导致死亡。Lamb colibacillosis, also known as lamb colibacillary diarrhea or lamb pullorum, is an acute infectious disease caused by Escherichia coli. The occurrence of the disease is related to factors such as poor climate environment, insufficient nutrition, damp sheep house, and poor sanitation environment. The disease is most likely to occur during winter and spring house feeding. Usually, the resistance of lambs due to this cause is reduced, and they lick contaminated ewe teats, utensils, objects, etc., and the germs reach the intestinal tract through the stomach, multiplying in large quantities in the intestinal tract, causing a large amount of intestinal fluid to accumulate, expanding the intestinal cavity, and stimulating intestinal peristalsis , causing diarrhea and eventually death due to dehydration, acidosis and disturbance of electrolyte balance.
发病羔羊最初精神不振,食欲明显减退,结膜潮红、腹胀、磨牙,呻吟。之后,排稀粪便呈黄糊状,个别病羊粪便中带有粘液,血液或脓液,严重病例粪便中带有肠黏膜。大多数出现腹泻症状的病羊,尾巴有水肿现象,个别耳部水肿。临床上常分为败血型和肠炎型(又称下痢型)两种证型。The affected lambs were initially depressed, with obvious loss of appetite, conjunctival flushing, abdominal distension, teeth grinding, and moaning. After that, the thin feces are yellow and pasty, with mucus, blood or pus in the feces of individual sick sheep, and intestinal mucosa in the feces of severe cases. Most of the sick sheep with diarrhea symptoms have edema in the tail and some ear edema. Clinically, it is often divided into two syndrome types: septicemia type and enteritis type (also known as diarrhea type).
败血型:常发病于 2~3 周龄的羔羊。病羊表现为精神不振、虚弱、嗜睡,口流泡沫,鼻流黏液,有轻微的腹泻症状,体温升高达到 41℃~42℃。随病情发展逐渐出现脑神经症状,视力障碍,盲目行走,头弯向一侧做转圈运动,步态蹒跚等行为,一般在病羊发病后 2天或数天内死亡。Septic blood type: usually occurs in lambs aged 2 to 3 weeks. The sick sheep manifested as lack of energy, weakness, lethargy, foamy mouth, mucus from the nose, mild diarrhea symptoms, and a rise in body temperature of 41°C to 42°C. With the development of the disease, symptoms of cranial nerves, visual impairment, blind walking, head bending to one side, staggering gait and other behaviors gradually appear. The sick sheep usually die within 2 days or a few days after the onset of the disease.
肠炎型(又称下痢型):多发生于2~8日龄的新生羔羊。病羊初期体温常常增高到41℃左右,当出现腹泻后体温会逐渐下降至正常,粪便起初呈浅黄色,成粥状,常伴有恶 臭味,继而发展成水样灰白色、含有乳凝块样的粪便,有时带有血丝和泡沫,通常患病羔羊肛门失禁,污染后驱和腿部,排粪时表现为极为痛苦。当羔羊出现严重脱水症状时,一般经 1~3 天死亡。Enteritis type (also known as diarrhea type): it mostly occurs in newborn lambs aged 2 to 8 days. The body temperature of sick sheep often rises to about 41°C at the beginning, and the body temperature will gradually drop to normal after diarrhea occurs. Feces like feces, sometimes bloodshot and foamy, usually sick lambs are anal incontinent, contaminate the hindquarters and legs, and are extremely painful when defecating. When lambs show severe dehydration symptoms, they usually die within 1 to 3 days.
本病严重影响羔羊的生长发育。因此,在生产实践中,羔羊大肠杆菌病的防治应被视为养羊疾病防制工作的重中之重。羔羊大肠杆菌病目前临床上主要使用抗生素治疗,抗生素虽然可以抑制或杀灭许多致病性大肠杆菌,但机体肠道除了致病性大肠杆菌外,还有大量的非致病性菌群,它们对机体的正常新陈代谢具有非常重要的作用,盲目使用抗生素也将抑制或杀灭许多非致病性菌群,并破坏其组成结构,严重影响机体的消化功能而加重病情;另外长期大量使用抗生素易产生抗药性。大肆滥用化药、抗生素及单体药物,既产生多元抗药和受体超敏等诸多药源性疾病,又造成畜禽产品污染,危及人类食品卫生安全。中药来源于动物、植物和矿物质,含有多种生物有效成分,其中大多数中药是以天然植物为原料,资源丰富,容易获取,效果良好,价格低廉,毒副作用微小,几乎无残留,无抗药性,不污染环境。因此,选用中药制剂替代化药、抗生素显得尤为重要。The disease seriously affects the growth and development of lambs. Therefore, in production practice, the prevention and treatment of lamb colibacillosis should be regarded as the top priority of sheep disease control. Lamb colibacillosis is currently mainly treated with antibiotics clinically. Although antibiotics can inhibit or kill many pathogenic E. coli, there are a large number of non-pathogenic bacteria in the intestinal tract of the body in addition to pathogenic E. coli. It plays a very important role in the normal metabolism of the body. Blind use of antibiotics will also inhibit or kill many non-pathogenic bacteria and destroy their composition, seriously affecting the digestive function of the body and aggravating the disease; develop drug resistance. The wanton abuse of chemical drugs, antibiotics and monomeric drugs not only produces many drug-induced diseases such as multidrug resistance and receptor hypersensitivity, but also causes pollution of livestock and poultry products, endangering human food hygiene and safety. Traditional Chinese medicine is derived from animals, plants and minerals, and contains a variety of biologically active ingredients. Most of them are made of natural plants. They are rich in resources, easy to obtain, good in effect, low in price, have minimal toxic and side effects, almost no residue, and no antibiotics. Medicinal properties, do not pollute the environment. Therefore, it is particularly important to select traditional Chinese medicine preparations to replace chemical medicines and antibiotics.
发明内容Contents of the invention
本发明要解决的技术问题是克服现有的缺陷,提供了一种治愈率高、毒副作用小、不易产生耐药性的防治羔羊大肠杆菌病的中药组合物;本发明还提供其制备方法和应用。The technical problem to be solved in the present invention is to overcome the existing defects, and to provide a traditional Chinese medicine composition for preventing and treating lamb colibacillosis with high cure rate, low toxicity and side effects, and resistance to drug resistance; the present invention also provides its preparation method and application.
本发明的第一个目的是提供一种防治羔羊大肠杆菌病的中药组合物,由以下重量份的组分制备完成:白头翁200±20份;蒲公英100±10份;马齿苋100±10份;吴茱萸180±10份;罂粟壳100±10份;五味子60±5份;焦三仙100±10份;茯苓100±10份;炙甘草60±5份。The first object of the present invention is to provide a traditional Chinese medicine composition for preventing and treating lamb colibacillosis, which is prepared from the following components by weight: 200 ± 20 parts of Pulsatillae; 100 ± 10 parts of dandelion; 100 ± 10 parts of purslane Evodia 180±10 parts; Poppy shell 100±10 parts; Schisandra 60±5 parts; Jiao Sanxian 100±10 parts; Poria 100±10 parts;
作为优选,由以下重量份的组分制备完成:白头翁200±10份;蒲公英100±5份;马齿苋100±5份;吴茱萸180±5份;罂粟壳100±5份;五味子60±2份;焦三仙100±5份;茯苓100±5份;炙甘草60±2份。Preferably, it is prepared from the following components by weight: 200±10 parts of Pulsatilla chinensis; 100±5 parts of dandelion; 100±5 parts of purslane; 180±5 parts of Evodia rutaecarpa; 100±5 parts of poppy shell; 100±5 parts of Jiao Sanxian; 100±5 parts of Poria cocos; 60±2 parts of roasted licorice.
最优选地,由以下重量份的组分制备完成:白头翁200份;蒲公英100份;马齿苋100份;吴茱萸180份;罂粟壳100份;五味子60份;焦三仙100份;茯苓100份;炙甘草60份。Most preferably, the preparation is completed by the following components by weight: 200 parts of Pulsatilla chinensis; 100 parts of dandelion; 100 parts of purslane; 180 parts of Evodia rutaecarpa; 100 parts of poppy shell; 60 parts of licorice.
在上述各优选条件下,得到的中药组合物的防治效果逐步提高。以最优选的条件下防治效果最佳。Under the above-mentioned optimal conditions, the control effect of the obtained traditional Chinese medicine composition is gradually improved. The control effect is the best under the most optimal conditions.
本发明的第二个目的是提供上述中药组合物的制备方法,是将配方量的各组分混合后,先水提再醇提制备而成的。The second object of the present invention is to provide a preparation method of the above-mentioned traditional Chinese medicine composition, which is prepared by mixing the components in the formula amount, firstly extracting with water and then extracting with alcohol.
作为优选,具体制备方法为:将配方量的各组分混合后,加入药材8-12倍重量的水,煎煮2次,每次90-120分钟,合并煎液,滤过,滤液静置取上清,并浓缩至相对密度为1.00-1.10,加乙醇至含醇量70-75%,放置,过滤,回收乙醇,加水至相对密度为1.00-1.10,灭菌即得;作为优选,醇提并加水至相对密度为1.00-1.10后,加入防霉剂,比如加入丙酸钙2g/kg药液或山梨酸钾2g/kg药液。As a preference, the specific preparation method is: after mixing the components of the formula amount, add 8-12 times the weight of the medicinal material in water, decoct twice, each time for 90-120 minutes, combine the decoction, filter, and let the filtrate stand Take the supernatant, concentrate it to a relative density of 1.00-1.10, add ethanol to an alcohol content of 70-75%, place it, filter it, recover the ethanol, add water to a relative density of 1.00-1.10, and sterilize it; as a preference, alcohol After extracting and adding water to a relative density of 1.00-1.10, add an antifungal agent, such as adding calcium propionate 2g/kg liquid or potassium sorbate 2g/kg liquid.
本发明的第三个目的是提供上述中药组合物在制备预防和/或治疗羔羊大肠杆菌病的药物中的应用。The third object of the present invention is to provide the application of the above-mentioned traditional Chinese medicine composition in the preparation of medicaments for preventing and/or treating lamb colibacillosis.
本发明的第四个目的是提供一种药物,所述药物的有效成分为上述的中药组合物。The fourth object of the present invention is to provide a medicine whose active ingredient is the above-mentioned traditional Chinese medicine composition.
作为优选,所述药物还包括医学上可接受的辅料。Preferably, the medicament also includes medically acceptable auxiliary materials.
作为优选,所述药物的剂型为口服液。Preferably, the dosage form of the medicine is oral liquid.
作为优选,所述药物的使用方法为:治疗量:羔羊、1-3ml/kg·BW、1次/d、连用5-7天;预防量:羔羊、2ml/kg·BW、1次/d、连用5-7天。Preferably, the method of using the drug is: therapeutic dose: lamb, 1-3ml/kg·BW, 1 time/d, consecutively for 5-7 days; preventive dose: lamb, 2ml/kg·BW, 1 time/d , Use continuously for 5-7 days.
羔羊腹泻多发生于秋冬春季节,羔羊脾胃虚弱,运化功能不强,又大多有贪凉和进食腐馊食物等情况,故认为本病主要由于感受寒湿秽浊之气及饮食不洁所致。中兽医认为本病的发生主要是(1)羔羊年幼,脾胃虚弱,运化功能不强,不能受纳水谷和运化精微,水谷停滞,清浊不分,混杂而下,遂成泄泻。如《景岳全书•泄泻》篇所谓:“泄泻之本,无不由于脾胃”。(2)感受时邪:秋冬之季,湿邪蒸腾,若调摄失宜,感受寒湿秽浊疫疠之气,或因贪凉露宿,寒湿入侵,客邪秽气,郁遏中焦,均能使脾胃受伤,运化失常,气机不利,升降失司,清浊相干,乱于肠胃而成泄泻。(3)饲喂不洁:饲喂不洁,误进腐馊变质食物,或寒凉饲料,最能损伤脾胃,清浊相混而成。Lamb diarrhea mostly occurs in autumn, winter and spring. Lambs have weak spleen and stomach, weak transport and transformation functions, and most of them have greed for cold and eat rotten food. Sincerely. Traditional Chinese veterinary medicine believes that the occurrence of this disease is mainly due to (1) the lamb is young, the spleen and stomach are weak, the transportation and transformation function is not strong, and it cannot absorb water and grains and the essence of transportation and transformation. . As it is said in "Jingyue Quanshu • Diarrhea": "The root of diarrhea is all due to the spleen and stomach". (2) Feel the evils of the season: In autumn and winter, damp evils are transpiring. If the adjustment is not appropriate, you feel the air of cold, damp, filthy, turbid and pestilence, or because you sleep in the open, the invasion of cold and damp, guest evils and foul air, and depression in the middle burner, you can all feel it. The spleen and stomach are injured, the transportation and transformation are abnormal, the movement of qi is unfavorable, the ascending and descending is lost, the turbidity is related, and the intestines and stomach are disordered to cause diarrhea. (3) Unclean feeding: Unclean feeding, rotten and degenerated food by mistake, or cold and cold feed can most damage the spleen and stomach, and it is formed by mixing turbidity and turbidity.
综上所述,本病主要是因羔羊脏腑娇嫩,形气未充或先天发育不良,后天营养不足,导致羔羊脾胃虚弱和抵抗力下降,感受湿秽浊之气,寒湿热毒之邪乘虚侵入脾胃,湿毒困脾,脾胃气虚,中阳不振,而致气机凝滞,升降逆乱,脾主运运化而升清阳,胃主受纳而降浊阴,今中虚有寒,升降失职,故为下利腹痛,不欲饮食;脾胃的消化吸收功能发生障碍,清浊不分混杂而下,湿热下迫,大小肠泌别失职,水湿不能分利而成泄泻,故粪稀、腥臭,或毒滞肠中,使肠道气血阻滞,化为脓白,故下痢色白或带脓白。治宜清热解毒、行血止痢、收敛固涩、健脾化湿、和胃止泻。To sum up, the disease is mainly due to the delicate viscera and viscera of the lamb, the lack of physical energy or congenital dysplasia, and the lack of acquired nutrition, which leads to the weakness of the spleen and stomach and the decline of resistance of the lamb. Spleen and stomach, dampness and poison trap the spleen, deficiency of spleen and stomach qi, and stagnation of yang in the middle, resulting in stagnation of qi movement, ups and downs and disorder, the spleen governs movement and transformation and raises clear yang, stomach governs acceptance and lowers turbid yin, now there is cold in the middle of the deficiency, and the rise and fall Dereliction of duty, so it is abdominal pain in the lower abdomen, and no desire to eat or drink; the digestion and absorption function of the spleen and stomach is disturbed, clear and turbid are mixed and descended, damp and hot are forced down, the large and small intestines are not secreted, and water and dampness cannot be divided, resulting in diarrhea, so feces Thin, fishy, or stagnant in the intestines, causing intestinal qi and blood to block and turn into white pus, so the diarrhea is white or white with pus. It is suitable for clearing away heat and detoxification, promoting blood circulation and stopping dysentery, astringent and astringent, invigorating the spleen and removing dampness, harmonizing the stomach and stopping diarrhea.
本发明药物是以用白头翁清热燥湿,凉血解毒,蒲公英清热解毒,消肿散结,二药为治疗此证君药。马齿苋具有清热解毒、散血消肿的功效,能治热痢脓血;罂粟壳涩肠止泻、止痛;五味子味酸收敛涩肠止泻,焦三仙健脾开胃、消食化积,解表化湿,行气消食、健脾开胃,茯苓健脾运湿止泻,以上五药共为臣药。吴茱萸辛温散寒,暖肝温胃,防治苦寒之药败胃伤阳之弊,是为反佐。炙甘草益气和中缓急,并能解诸药之毒,又能缓和诸药辛烈之性为使,诸药共用,标本兼治,正气通畅,则邪逆自除矣。The medicine of the present invention is to clear away heat and dampness with Pulsatilla grandis, cool blood and detoxify, dandelion clears heat and detoxifies, reduces swelling and dissipates stagnation, and the two medicines are the king medicines for treating this syndrome. Purslane has the effect of clearing heat and detoxifying, dissipating blood and reducing swelling, and can cure dysentery and pus and blood; poppy shell astringent intestines to stop diarrhea and relieve pain; Dispelling dampness, promoting qi and promoting digestion, invigorating the spleen and whetting the appetite, Poria cocos invigorating the spleen, transporting dampness and stopping diarrhea, the above five medicines are ministerial medicines altogether. Evodia rutaecarpa is pungent, warms and dispels cold, warms the liver and stomach, and prevents the disadvantages of the bitter cold medicine from defeating the stomach and injuring the yang, and it is an anti-adjuvant. Roasted Glycyrrhiza invigorates the Qi, harmonizes the urgency, can detoxify the poison of various medicines, and alleviate the pungent nature of the medicines. When all medicines are used together, both symptoms and root causes can be treated, and the righteous qi will be unobstructed, and the evil will be eliminated by itself.
本发明药品由白头翁、蒲公英、马齿苋、罂粟壳等中药浓缩而成,以健脾祛湿、和胃解毒治本,行血止痢、收敛固涩、和胃止泻达到治疗羔羊大肠杆菌病的目的。组方充分参照中兽医八纲、脏腑辨证理论,表里兼顾,气血同治,用药精专,配伍谨严,体现了用药如用兵,用兵之道在于精,用药之道在于纯的组方特性。The medicine of the present invention is concentrated from traditional Chinese medicines such as pulsatilla, dandelion, purslane, poppy husk, etc., to invigorate the spleen and eliminate dampness, harmonize the stomach and detoxify the root cause, promote blood flow and stop dysentery, astringe and astringe, harmonize the stomach and relieve diarrhea to treat lamb colibacillosis the goal of. The formula fully refers to the eight principles of veterinary medicine and the theory of syndrome differentiation of viscera and viscera, taking into account both the exterior and the interior, treating qi and blood at the same time, precise and specialized medicine, and strict compatibility.
现代兽医药理研究和临床长期应用的实践证明,中药具有整体疗效高,不易产生耐药性,残留低,毒副作用小等优点,其对许多细菌病原的生长与繁殖具有显著的抑制作用,甚至达到杀灭病原的药理效果。本发明根据羔羊大肠杆菌病的的病因,发病机制,临床病理和药物作用机理,进行中药复方防治羔羊大肠杆菌病,研制开发出疗效显著,质量可靠,应用方便,价格低廉的中药复方制剂,并在养羊生产中推广应用,对于促进养羊业的健康发展具有十分重要的经济和社会意义。Modern veterinary pharmacological research and long-term clinical practice have proved that traditional Chinese medicine has the advantages of high overall curative effect, low drug resistance, low residue, and small toxic and side effects. It has a significant inhibitory effect on the growth and reproduction of many bacterial pathogens, even reaching The pharmacological effect of killing pathogens. According to the etiology, pathogenesis, clinical pathology and drug action mechanism of lamb colibacillosis, the present invention carries out the prevention and treatment of lamb colibacillosis with traditional Chinese medicine compound, and develops a Chinese medicine compound preparation with remarkable curative effect, reliable quality, convenient application and low price, and It is of great economic and social significance to promote the healthy development of sheep raising industry in sheep raising production.
本发明的优点和有益效果为:1、本发明采用中医兽医疗法,采用纯中药组分,口服下列中药,羔羊食用后治愈快,无副作用,有利于羔羊的生长。2、本发明的中药药液调制简单、使用方便,原料成本低廉,用后无毒性反应、治愈率也高、无残留,是一种理想的防治羔羊大肠杆菌病的药物。The advantages and beneficial effects of the present invention are as follows: 1. The present invention adopts traditional Chinese medicine veterinary medicine, adopts pure Chinese medicine components, and takes the following Chinese medicines orally. After eating, lambs are cured quickly without side effects, which is beneficial to the growth of lambs. 2. The traditional Chinese medicine liquid of the present invention is simple to prepare, easy to use, low in cost of raw materials, has no toxic reaction after use, has a high cure rate, and has no residue. It is an ideal medicine for preventing and treating lamb colibacillosis.
本发明的药物在具体使用时可直接供羔羊灌服。The medicament of the present invention can be directly fed to lambs when it is specifically used.
本发明的药物的使用量为:治疗量:羔羊、1-3ml/kg·BW(最优为2ml/kg·BW)、1次/d、连用5-7天;预防量:羔羊、2ml/kg·BW、1次/d、连用7d。The dosage of the medicine of the present invention is: therapeutic dose: lamb, 1-3ml/kg·BW (optimally 2ml/kg·BW), 1 time/d, continuous use for 5-7 days; preventive dose: lamb, 2ml/kg·BW kg·BW, 1 time/d, consecutively for 7 days.
具体实施方式detailed description
以下的实施例便于更好地理解本发明,但并不限定本发明。下述实施例中的实验方法,如无特殊说明,均为常规方法。下述实施例中所用的试验材料,如无特殊说明,均为市售。The following examples facilitate a better understanding of the present invention, but do not limit the present invention. The experimental methods in the following examples are conventional methods unless otherwise specified. The test materials used in the following examples are commercially available unless otherwise specified.
本发明的一种防治羔羊大肠杆菌病的中药组合物,由以下重量份的组分制备完成:A kind of traditional Chinese medicine composition for preventing and treating lamb colibacillosis of the present invention is prepared from the following components by weight:
白头翁200±20份;蒲公英100±10份;马齿苋100±10份;吴茱萸180±10份;罂粟壳100±10份;五味子60±5份;焦三仙100±10份;茯苓100±10份;炙甘草60±5份。Pulsatilla 200±20 parts; Dandelion 100±10 parts; Purslane 100±10 parts; Evodia 180±10 parts; Poppy husk 100±10 parts; 60 ± 5 parts of roasted licorice.
本发明的防治羔羊大肠杆菌病的中药组合物的制备方法,包括以下步骤:The preparation method of the Chinese medicine composition of preventing and treating lamb colibacillosis of the present invention may further comprise the steps:
按重量份数取各组分,加药材8-12倍重量的水,煎煮2次,每次90-120分钟,合并煎液,滤过,滤液静置12小时,取上清液浓缩至相对密度为1.00~1.10,加乙醇至含醇量70-75%,放置,滤过,回收乙醇,加水至相对密度为1.00~1.10,加入丙酸钙2g/kg药液或山梨酸钾2g/kg药液,混均,冷却24h,滤过用棕色无菌聚酯瓶分装,100℃流通蒸汽50-60分钟,即得。Take each component in parts by weight, add water with 8-12 times the weight of the medicinal material, decoct twice, 90-120 minutes each time, combine the decoction, filter, leave the filtrate for 12 hours, take the supernatant and concentrate to The relative density is 1.00-1.10, add ethanol to the alcohol content of 70-75%, place, filter, recover ethanol, add water to the relative density of 1.00-1.10, add calcium propionate 2g/kg liquid or potassium sorbate 2g/ kg of liquid medicine, mixed evenly, cooled for 24 hours, filtered and divided into brown sterile polyester bottles, and steamed at 100°C for 50-60 minutes to obtain the product.
本发明的药物的使用量为:治疗量:羔羊、1-3ml/kg·BW(最优为2ml/kg·BW)、1次/d、连用5-7天;预防量:羔羊、2ml/kg·BW、1次/d、连用7d。The dosage of the medicine of the present invention is: therapeutic dose: lamb, 1-3ml/kg·BW (optimally 2ml/kg·BW), 1 time/d, continuous use for 5-7 days; preventive dose: lamb, 2ml/kg·BW kg·BW, 1 time/d, consecutively for 7 days.
在上述范围内制备得到的中药组合物均能有效防治羔羊大肠杆菌病,在上述服用量和服用时间的情况下,高剂量(3ml/kg·BW)的治愈率在88.4%以上,中剂量(2ml/kg·BW)的治愈率在85.6%以上,低剂量(1ml/kg·BW)的治愈率在71.3%以上;在上述服用量和服用时间的情况下,中剂量预防组羔羊大肠杆菌病的发病率低于5%,预防组在发病后给予治疗后,治愈率在84%以上。The traditional Chinese medicine composition prepared within the above range can effectively prevent and treat lamb colibacillosis. Under the above-mentioned dosage and taking time, the cure rate of the high dose (3ml/kg·BW) is above 88.4%, and the medium dose ( 2ml/kg·BW) the cure rate is above 85.6%, and the cure rate of the low dose (1ml/kg·BW) is above 71.3%. The incidence rate of the disease is less than 5%, and the cure rate of the prevention group is above 84% after treatment is given after the onset.
以下为几个优选实施例,其中以实施例1制备的中药制剂的治疗效果最佳。Below are several preferred embodiments, wherein the therapeutic effect of the Chinese medicine preparation prepared in Example 1 is the best.
实施例1Example 1
本发明的一种防治羔羊大肠杆菌病的中药组合物的配方如下:The formula of a kind of Chinese medicine composition of preventing and treating lamb colibacillosis of the present invention is as follows:
白头翁200g;蒲公英100 g;马齿苋100 g;吴茱萸180 g;罂粟壳100 g;五味子60 g;焦三仙100 g;茯苓100 g;炙甘草60 g。Pulsatilla 200g; Dandelion 100g; Purslane 100g; Evodia 180g; Poppy shell 100g; Schisandra 60g; Jiao Sanxian 100g;
本发明的一种防治羔羊大肠杆菌病的中药组合物的制备方法为:The preparation method of a kind of Chinese medicine composition of preventing and treating lamb colibacillosis of the present invention is:
称取配方量的各组分,加药材8倍重量的水,煎煮2次,每次90分钟,合并煎液,滤过,滤液静置12小时,取上清液浓缩至相对密度为1.05,加乙醇至含醇量70%,放置,滤过,回收乙醇,加水至相对密度为1.05,加入丙酸钙2g/kg药液,混均,冷却24h,滤过用棕色无菌聚酯瓶分装,100℃流通蒸汽50分钟,即得。Weigh each component of the formula amount, add 8 times the weight of the medicinal material, decoct twice, 90 minutes each time, combine the decoction, filter, let the filtrate stand for 12 hours, take the supernatant and concentrate to a relative density of 1.05 , add ethanol to 70% alcohol content, place, filter, recover ethanol, add water to a relative density of 1.05, add calcium propionate 2g/kg liquid, mix well, cool for 24 hours, filter with a brown sterile polyester bottle Subpackaged, steamed at 100°C for 50 minutes, ready to serve.
实施例2Example 2
本发明的一种防治羔羊大肠杆菌病的中药组合物的配方如下:The formula of a kind of Chinese medicine composition of preventing and treating lamb colibacillosis of the present invention is as follows:
白头翁210g;蒲公英95g;马齿苋95g;吴茱萸185g;罂粟壳95g;五味子62g;焦三仙105g;茯苓95g;炙甘草58g。Pulsatilla 210g; Dandelion 95g; Purslane 95g; Evodia 185g; Poppy shell 95g;
本发明的一种防治羔羊大肠杆菌病的中药组合物的制备方法为:The preparation method of a kind of Chinese medicine composition of preventing and treating lamb colibacillosis of the present invention is:
按重量份数取各组分,加药材10倍重量的水,煎煮2次,每次100分钟,合并煎液,滤过,滤液静置12小时,取上清液浓缩至相对密度为1.00,加乙醇至含醇量75%,放置,滤过,回收乙醇,加水至相对密度为1.00,加入山梨酸钾2g/kg药液,混均,冷却24h,滤过用棕色无菌聚酯瓶分装,100℃流通蒸汽60分钟,即得。Take each component in parts by weight, add water 10 times the weight of the medicinal material, decoct twice, 100 minutes each time, combine the decoction, filter, let the filtrate stand for 12 hours, take the supernatant and concentrate to a relative density of 1.00 , add ethanol to 75% alcohol content, place, filter, recover ethanol, add water to a relative density of 1.00, add potassium sorbate 2g/kg liquid, mix well, cool for 24 hours, filter with a brown sterile polyester bottle Subpackaged, steamed at 100°C for 60 minutes, ready to serve.
实施例3Example 3
本发明的一种防治羔羊大肠杆菌病的中药组合物的配方如下:The formula of a kind of Chinese medicine composition of preventing and treating lamb colibacillosis of the present invention is as follows:
白头翁190g;蒲公英105g;马齿苋105g;吴茱萸175g;罂粟壳105g;五味子58g;焦三仙95g;茯苓105g;炙甘草62g。Pulsatilla 190g; Dandelion 105g; Purslane 105g; Evodia 175g; Poppy shell 105g;
本发明的一种防治羔羊大肠杆菌病的中药组合物的制备方法为:The preparation method of a kind of Chinese medicine composition of preventing and treating lamb colibacillosis of the present invention is:
按重量份数取各组分,加药材12倍重量的水,煎煮2次,每次120分钟,合并煎液,滤过,滤液静置12小时,取上清液浓缩至相对密度为1.10,加乙醇至含醇量72%,放置,滤过,回收乙醇,加水至相对密度为1.10,加入丙酸钙2g/kg药液,混均,冷却24h,滤过用棕色无菌聚酯瓶分装,100℃流通蒸汽50分钟,即得。Take each component in parts by weight, add water with 12 times the weight of the medicinal material, decoct twice for 120 minutes each time, combine the decoction, filter, let the filtrate stand for 12 hours, take the supernatant and concentrate to a relative density of 1.10 , add ethanol to 72% alcohol content, place, filter, recover ethanol, add water to a relative density of 1.10, add calcium propionate 2g/kg liquid, mix well, cool for 24 hours, filter with a brown sterile polyester bottle Subpackaged, steamed at 100°C for 50 minutes, ready to serve.
实施例4Example 4
本发明的一种防治羔羊大肠杆菌病的中药组合物的配方如下:The formula of a kind of Chinese medicine composition of preventing and treating lamb colibacillosis of the present invention is as follows:
白头翁180g;蒲公英110g;马齿苋110g;吴茱萸170g;罂粟壳90g;五味子55g;焦三仙110g;茯苓110g;炙甘草65g。Pulsatilla 180g; Dandelion 110g; Purslane 110g; Evodia 170g; Poppy shell 90g;
本发明的一种防治羔羊大肠杆菌病的中药组合物的制备方法为:The preparation method of a kind of Chinese medicine composition of preventing and treating lamb colibacillosis of the present invention is:
按重量份数取各组分,加药材10倍重量的水,煎煮2次,每次110分钟,合并煎液,滤过,滤液静置12小时,取上清液浓缩至相对密度为1.05,加乙醇至含醇量72%,放置,滤过,回收乙醇,加水至相对密度为1.00,加入山梨酸钾2g/kg药液,混均,冷却24h,滤过用棕色无菌聚酯瓶分装,100℃流通蒸汽52分钟,即得。Take each component in parts by weight, add water 10 times the weight of the medicinal material, decoct twice, 110 minutes each time, combine the decoction, filter, let the filtrate stand for 12 hours, take the supernatant and concentrate to a relative density of 1.05 , add ethanol to 72% alcohol content, place, filter, recover ethanol, add water to a relative density of 1.00, add potassium sorbate 2g/kg liquid, mix well, cool for 24 hours, filter with a brown sterile polyester bottle Dispense, and circulate steam at 100°C for 52 minutes to obtain the product.
实施例5Example 5
本发明的一种防治羔羊大肠杆菌病的中药组合物的配方如下:The formula of a kind of Chinese medicine composition of preventing and treating lamb colibacillosis of the present invention is as follows:
白头翁220g;蒲公英90g;马齿苋90g;吴茱萸190g;罂粟壳110g;五味子65g;焦三仙90g;茯苓90g;炙甘草55g。Pulsatilla 220g; Dandelion 90g; Purslane 90g; Evodia 190g; Poppy shell 110g;
本发明的一种防治羔羊大肠杆菌病的中药组合物的制备方法为:The preparation method of a kind of Chinese medicine composition of preventing and treating lamb colibacillosis of the present invention is:
按重量份数取各组分,加药材11倍重量的水,煎煮2次,每次100分钟,合并煎液,滤过,滤液静置12小时,取上清液浓缩至相对密度为1.10,加乙醇至含醇量70%,放置,滤过,回收乙醇,加水至相对密度为1.10,加入丙酸钙2g/kg药液,混均,冷却24h,滤过用棕色无菌聚酯瓶分装,100℃流通蒸汽60分钟,即得。Take each component according to parts by weight, add 11 times the weight of the medicinal materials, decoct twice, 100 minutes each time, combine the decoction, filter, let the filtrate stand for 12 hours, take the supernatant and concentrate to a relative density of 1.10 , add ethanol to 70% alcohol content, place, filter, recover ethanol, add water to a relative density of 1.10, add calcium propionate 2g/kg liquid, mix well, cool for 24 hours, filter with a brown sterile polyester bottle Subpackaged, steamed at 100°C for 60 minutes, ready to serve.
实施例6 应用实施例Example 6 Application Example
1)治疗试验:1) Treatment trials:
本申请人采用随机双盲试验法进行了不同剂量治疗自然发病的羔羊大肠杆菌病治疗试验,并选用硫酸粘菌素注射液为阳性药物对照组。观察本发明对羔羊大肠杆菌病治疗作用,以探讨其在畜禽生产中应用的可行性。The applicant has carried out a randomized double-blind test method to treat natural lamb colibacillosis with different doses, and selected colistin sulfate injection as the positive drug control group. Observe the therapeutic effect of the present invention on lamb colibacillosis, so as to explore the feasibility of its application in livestock and poultry production.
对自然发病的羔羊大肠杆菌病的治疗试验:将自然发病经临床诊断和实验室诊断确诊为羔羊大肠杆菌病的病羔羊随机分为5组,每组36只。第1-3组为采用本发明实施例1制备的药物治疗组(分别设高、中、低剂量三个组);第4组为硫酸粘菌素注射液阳性药物对照组;第5组为阳性对照组(感染,不给药)。分别隔离饲养,详细记录病羔羊的症状、治愈、死亡等情况。Therapeutic test on naturally occurring lamb colibacillosis: the naturally occurring diseased lambs diagnosed as lamb colibacillosis through clinical diagnosis and laboratory diagnosis were randomly divided into 5 groups, 36 in each group. Group 1-3 is the drug treatment group prepared by Example 1 of the present invention (three groups of high, medium and low doses are set up respectively); the 4th group is the positive drug control group of colistin sulfate injection; the 5th group is Positive control group (infection, no administration). They were kept in isolation, and the symptoms, cure, and death of the sick lambs were recorded in detail.
给药方法、用药时间:药物1组:每只羔羊每次饲喂本发明实施例1制备的药物3ml/kg·BW,每日一次,连喂7天;药物2组:每只羔羊每次饲喂本发明实施例1制备的药物2ml/kg·BW,每日一次,连喂7天;药物3组:每只羔羊每次饲喂本发明实施例1制备的药物1ml/kg·BW,每日一次,连喂7天。阳性药物对照组:每只羔羊每日使用硫酸粘菌素注射液(按说明书使用),连用7天;阳性对照组:不给药。Dosing method, medication time: medicine 1 group: each lamb is fed with 3ml/kg·BW of the medicine prepared in Example 1 of the present invention each time, once a day, and fed continuously for 7 days; medicine 2 groups: each lamb is fed every time Feeding 2ml/kg BW of the medicine prepared in Example 1 of the present invention once a day for 7 days; 3 groups of medicine: each lamb was fed with 1ml/kg BW of the medicine prepared in Example 1 of the present invention each time, Once a day, even for 7 days. Positive drug control group: each lamb was given colistin sulfate injection (according to the instructions) every day for 7 consecutive days; positive control group: no administration.
实验结果:Experimental results:
治疗组喂药24h后,药物组病羔羊的精神比阳性对照组要好,36 h后统计死亡数,药物组病羔羊比阳性对照组死亡数明显少;48h后观察,药物各组出现不同程度的好转,阳性对照组仍有陆续死亡发生。3d后,药物组病羔的精神、食欲大有好转(从吃奶量、喂料量增多看出),粪便正常。5d后,药物组病羔恢复正常。After the treatment group fed the drug for 24 hours, the spirit of the diseased lambs in the drug group was better than that of the positive control group. After 36 hours, the number of deaths was counted, and the number of deaths of the diseased lambs in the drug group was significantly less than that of the positive control group; Things got better, but the positive control group still died one after another. After 3 days, the spirit and appetite of the sick lambs in the drug group were greatly improved (as seen from the increase in the amount of milk and feed), and the feces were normal. After 5 days, the sick lambs in the drug group returned to normal.
试验统计结果表明本发明药物高剂量治疗组36只羔羊中,有32只痊愈,4只仍拉稀,但没有死亡,治愈率为88.9%;中剂量治疗组36只羔羊中,有31只痊愈,5只仍拉稀,但没有死亡,治愈率为86.1%;低剂量治疗组36只羔羊中,有26只痊愈,8只仍拉稀,死亡2只,治愈率为72.2%;硫酸粘菌素注射液治疗组(对照组)36只羔羊中,有26只痊愈,5只仍拉稀,并有5只死亡,治愈率为72.2%;阳性对照组(不给药)36只羔羊中,有24只仍拉稀,并有12只死亡。高、中剂量治疗组死亡率为0.0%,且治疗组病羔羊较对照组病羔羊,表现为症状减轻,病程缩短,实验证明本发明高、中、低剂量对羔羊大肠杆菌病都有治疗作用,能缓解症状,降低死亡率,且高、中剂量在降低死亡率,提高治愈率等方面均优于硫酸粘菌素注射液的效果。高、中剂量本发明都可以达到治病、提高存活率的效果,且两者在0.05水平上无差异,故临床使用时可采用中剂量,这样既经济疗效又显著。The statistical results of the test show that among the 36 lambs of the high-dose treatment group of the present invention, 32 were cured, and 4 were still loose, but did not die, and the cure rate was 88.9%; among the 36 lambs of the middle-dose treatment group, 31 were fully recovered. 5 lambs still had diarrhea, but no death, the cure rate was 86.1%; among the 36 lambs in the low-dose treatment group, 26 lambs were cured, 8 lambs were still diarrhea, and 2 died, the cure rate was 72.2%; colistin sulfate injection Of the 36 lambs in the treatment group (control group), 26 were cured, 5 were still diarrhea, and 5 died, the cure rate was 72.2%. Among the 36 lambs in the positive control group (no administration), 24 were still diarrhea. diarrhea, and 12 died. The death rate of the high and middle dose treatment groups is 0.0%, and the sick lambs of the treatment group are compared with the sick lambs of the control group, showing that the symptoms are alleviated, and the course of disease is shortened. Experiments prove that the high, middle and low doses of the present invention have a therapeutic effect on lamb colibacillosis , can relieve symptoms and reduce mortality, and high and medium doses are superior to colistin sulfate injection in reducing mortality and improving the cure rate. Both high and medium doses of the present invention can achieve the effect of curing diseases and improving the survival rate, and there is no difference between the two at the level of 0.05, so the medium dose can be used in clinical use, which is economical and effective.
2)预防试验2) Prevention test
在疫情发生的羊场,将120只健康未发病羔羊随机分为2组,每组60只,第1组为药物预防组;第2组为对照组;第1组每只羔羊每日灌服本发明实施例1制备的药物2ml/kg·BW,连喂7天;第2组不添加任何药物;两组羔羊其它措施皆按羊场正常消毒免疫程序。In the sheep farm where the epidemic occurred, 120 healthy lambs without disease were randomly divided into 2 groups, 60 in each group, the first group was the drug prevention group; the second group was the control group; each lamb in the first group was fed daily The medicine 2ml/kg·BW that the embodiment 1 of the present invention prepares is fed continuously for 7 days; The 2nd group does not add any medicine; Other measures of two groups of lambs are all according to the normal disinfection and immunization procedure of the sheep farm.
结果表明:药物预防组羔羊大肠杆菌病的发病率为3.0%,对照组发病率为75.0%,且药物组发病羔羊的精神、食欲皆优于对照组,患病症状也较对照组轻。预防组在发病后给与治疗后,治愈率为86.0%;而对照组为67.0%。The results showed that the incidence of colibacillosis in lambs in the drug prevention group was 3.0%, and that in the control group was 75.0%. The spirit and appetite of the lambs in the drug group were better than those in the control group, and the disease symptoms were lighter than those in the control group. After the prevention group was given treatment after the onset, the cure rate was 86.0%, while that of the control group was 67.0%.
从试验结果来看,本发明具有益气健脾化湿、扶正祛邪、和胃止泻、收敛固涩、解毒排浊、散寒止痛的功能。在临床试验过程中未发现该药有不良反应。高、中、低剂量对羔羊大肠杆菌病病有较好的治疗效果。低剂量组的治疗效果低于高、中剂量组,中、高剂量组在死亡率、治愈率和总有效率方面均无显著性差异。应根据病情的轻重和治疗成本,建议临床应用以中、高剂量(羔羊10-15ml);为好,连用7天(为确保疗效)。From the test results, the present invention has the functions of replenishing qi, invigorating the spleen and removing dampness, strengthening the body and dispelling pathogenic factors, harmonizing the stomach and relieving diarrhea, astringent and astringent, detoxification and turbidity removal, dispelling cold and relieving pain. No adverse reactions were found in the drug during the clinical trials. High, medium and low doses have a good therapeutic effect on lamb colibacillosis. The therapeutic effect of the low-dose group was lower than that of the high-dose and middle-dose groups, and there was no significant difference in mortality, cure rate and total effective rate between the middle-dose and high-dose groups. According to the severity of the disease and the cost of treatment, it is recommended to use medium and high doses (lamb 10-15ml) for clinical application; preferably, it should be used continuously for 7 days (to ensure the curative effect).
本发明的药物按照上市包装条件,于温度:40℃±2℃,相对湿度:75%±5%条件下加速实验3个月,质量无明显变化。于温度:25℃±2℃相对湿度:60%±10%条件下长期试验24个月,质量无明显变化。上述试验结果表明,本发明的药物在规定条件下贮藏质量稳定。The drug of the present invention is subjected to an accelerated test for 3 months under the condition of temperature: 40°C±2°C and relative humidity: 75%±5% according to the packaging conditions on the market, and the quality has no obvious change. In the long-term test for 24 months under the condition of temperature: 25℃±2℃ and relative humidity: 60%±10%, the quality has no obvious change. The above test results show that the medicine of the present invention is stable in storage quality under specified conditions.
最后应说明的是:以上所述仅为本发明的优选实施例而已,并不用于限制本发明,尽管参照前述实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。Finally, it should be noted that: the above is only a preferred embodiment of the present invention, and is not intended to limit the present invention. Although the present invention has been described in detail with reference to the foregoing embodiments, for those skilled in the art, it still The technical solutions recorded in the foregoing embodiments may be modified, or some technical features thereof may be equivalently replaced. Any modifications, equivalent replacements, improvements, etc. made within the spirit and principles of the present invention shall be included within the protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610933301.9A CN106389962A (en) | 2016-10-25 | 2016-10-25 | Traditional Chinese medicinal composition for preventing and treating lamb colibacillosis, and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610933301.9A CN106389962A (en) | 2016-10-25 | 2016-10-25 | Traditional Chinese medicinal composition for preventing and treating lamb colibacillosis, and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106389962A true CN106389962A (en) | 2017-02-15 |
Family
ID=58012965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610933301.9A Pending CN106389962A (en) | 2016-10-25 | 2016-10-25 | Traditional Chinese medicinal composition for preventing and treating lamb colibacillosis, and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106389962A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107495090A (en) * | 2017-07-29 | 2017-12-22 | 贵州省华腾农业科技有限公司 | A kind of myotonin deep process |
CN115721680A (en) * | 2021-08-26 | 2023-03-03 | 河北征宇制药有限公司 | Traditional Chinese medicine composition for effectively reducing drug resistance of pathogenic escherichia coli of chicken and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103394053A (en) * | 2013-07-18 | 2013-11-20 | 中国农业科学院兰州畜牧与兽药研究所 | Traditional Chinese medicine composition capable of preventing and treating piglet yellow and white scours as well as preparation and applications thereof |
-
2016
- 2016-10-25 CN CN201610933301.9A patent/CN106389962A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103394053A (en) * | 2013-07-18 | 2013-11-20 | 中国农业科学院兰州畜牧与兽药研究所 | Traditional Chinese medicine composition capable of preventing and treating piglet yellow and white scours as well as preparation and applications thereof |
Non-Patent Citations (1)
Title |
---|
朱进忠等,: "《朱进忠老中医用药经验真传》", 30 June 2016, 山西科学技术出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107495090A (en) * | 2017-07-29 | 2017-12-22 | 贵州省华腾农业科技有限公司 | A kind of myotonin deep process |
CN115721680A (en) * | 2021-08-26 | 2023-03-03 | 河北征宇制药有限公司 | Traditional Chinese medicine composition for effectively reducing drug resistance of pathogenic escherichia coli of chicken and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103394053B (en) | Traditional Chinese medicine composition capable of preventing and treating piglet yellow and white scours as well as preparation and applications thereof | |
CN103230574A (en) | Traditional Chinese medical composition for treating porcine epizootic diarrhea and application thereof | |
CN102973829B (en) | Feed for treating diarrhea of dairy cow | |
CN106389962A (en) | Traditional Chinese medicinal composition for preventing and treating lamb colibacillosis, and preparation method and application thereof | |
CN102600282B (en) | Medicine for treating deficiency-cold calf diarrhea and preparation method thereof | |
CN110507771B (en) | Medicine for preventing and treating animal digestive syndrome and preparation method thereof | |
CN104547997A (en) | Traditional Chinese medicinal composition for treating epidemic diarrhea of piglet | |
KR20180039813A (en) | Composition Comprising Plant Extracts for Prevention of Diseases and Enhancement of Immune System for Animals and Manufacturing Method for Drinking Water | |
CN109224024B (en) | Pharmaceutical composition for preventing and treating bacterial mixed infection of freshwater fish and application method thereof | |
CN103768189B (en) | The Chinese medicine for the treatment of cattle hemorrhagic enteritis | |
CN107397886A (en) | Chinese medicine composition for preventing and treating piglet red dysentery and its preparation method and application | |
CN104940291A (en) | Composition for preventing and treating honeybee microsporidiosis and use thereof | |
CN105560444B (en) | A Tibetan medicine composition for treating yak gastroenteritis and its preparation method and application | |
CN115886252A (en) | A food composition for promoting sleep and regulating depression and its preparation method | |
CN104940307B (en) | A kind of Chinese medicine composition and purposes for preventing Nosema apis parasitosis | |
CN106310035A (en) | Traditional Chinese medicine composition capable of preventing paratyphoid fever of lambs, and preparation method thereof | |
CN101829257B (en) | Traditional Chinese medicine oral liquid for treating chicken colibacillosis and preparation method thereof | |
CN105920377A (en) | Feed additive for control of soft-shelled turtle putred-skin disease and preparation method thereof | |
CN113082140B (en) | A kind of traditional Chinese medicine compound for treating acute mastitis in dairy cows and preparation method thereof | |
AU2021105905A4 (en) | A Pharmaceutical Composition for Treating Diarrhea Of Piglet And Its Preparation Method | |
CN103191400A (en) | Traditional Chinese medicine compound drug for preventing and treating transmissible gastroenteritis of swine | |
CN108096500A (en) | It is a kind of for treating Chinese medicine composition that sow postpartum do not eat and its preparation method and application | |
CN107669960A (en) | A kind of composition for preventing and treating loach saprolegniasis and preparation method thereof | |
CN106334136A (en) | Traditional Chinese medicine composition for preventing and treating clostridium dysentery of lambs and preparation method thereof | |
CN104208090B (en) | A kind of preventing and treating Bovine Ephemeral Fever compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170215 |